Precision Optics price to free cash flow POCI

Market value divided by free cash flow over the last twelve months, since 2018.

Today, Oct 23, 2026: n/m; not a meaningful number
Last meaningful: 88.8×; Sep 2023
8-year median: 89.7×
8-year range: 76.6× to 171×
Peer median: 11.8×

Precision Optics' price to free cash flow is not a meaningful number today: free cash flow over the last twelve months was zero, negative or not reported.

It was last meaningful in Sep 2023, at 88.8×.

On the days it had one over the last 8 years, its median was 89.7×, from 76.6× in Feb 2019 to 171× in Sep 2018.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	88.8×	85.3×	100×
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	92.6×	76.6×	92.6×
2018	89.3×	83.3×	171×

Against its peers

Companies in Healthcare nearest Precision Optics' size, closest first, today.

Company	Price to free cash flow
POCIPrecision Optics	n/m
ATNMActinium Pharmaceuticals	n/m
APTAlpha Pro Tech	9.7×
NEPHNephros	n/m
SPROSpero Therapeutics	n/m
LFVNLifevantage	11.0×
ICCCImmucell	22.1×
KEQUKewaunee Scientific	8.7×
PDEXPro DEX	29.5×
PLXProtalix BioTherapeutics	26.8×
NATRNatures Sunshine Products	11.8×
Peer median	11.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Precision Optics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.